Immunolocalisation of tenascin-C in focal reactive overgrowths of oral mucosa

Journal of Oral Pathology and Medicine

Volumn 25, Issue 4, 1996, Pages 163-169

  Mighell, Alan J ^a   Robinson, Philip A ^a   Hume, William J ^a  

^a LEEDS DENTAL INSTITUTE   (United Kingdom)

Author keywords

epulis; fibrous hyperplasia; giant cell granuloma; immunohistochemistry; ossification; pyogenic granuloma; tenascin

Indexed keywords

EID: 0030130539     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1996.tb00214.x     Document Type: Article

References (39)

1. REGEZI JA, COURTNEY RM, KERR DA. Fibrous lesions of the skin and mucous membranes which contain stellate and multinucleated cells. Oral Surg Oral Med Oral Pathol 1975; 39: 605-14.
2. REIBEL J. Oral fibrous hyperplasias containing stellate and multinucleated cells. Scand J Dent Res 1982; 90: 217-26.
3. SAVAGE NW, MONSOUR PA. Oral fibrous hyperplasias and the giant cell fibroma. Aus Dent J 1985; 30: 405-9.
4. ERICKSON HP. Tenascin-C, tenascin-R, and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol 1993; 5: 869-76.
5. LIGHTNER VA. Tenascin: does it play a role in epidermal morphogenesis and homeostasis? J Invest Dermatol 1994; 102: 273-7.
6. CHIQUET-EHRISMANN R, HAGIOS C, MATSUMOTO K. The tenascin gene family. Perspect Dev Neurobiol 1994; 2: 3-7.
7. SAGA Y, YAGI T, IKAWA Y, SAKAKURA T, AIZAWA S. Mice develop normally without tenascin. Genes Dev 1992; 6: 1821-31.
8. SLOAN P, SCHOR SL, LOPES V, CHIQUET-EHRISMANN R. Immunohistochemical study of the heterogeneity of tenascin distribution within the oral mucosa of the mouse. Arch Oral Biol 1990; 35: 67-70.
9. TUCKER RP. The in-situ localisation of tenascin splice variants and thrombospondin 2 mRNA in the avian embryo. Development 1993; 117: 347-58.
10. TUCKER RP, HAMMARBACK JA, JENRATH DA, MACKIE EJ, XU Y. Tenascin expression in the mouse: in-situ localisation and induction in-vitro by bFGF. J Cell Sci 1993; 104: 69-76.
11. MATSUMOTO K, SAGA Y, IKEMURA T, SAKAKURA T, CHIQUET-EHRISMANN R. The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. J Cell Biol 1994; 125: 483-93.
12. BORSI L, CARNEMOLLA B, NICOLO G, SPINA B, TANARA G, ZARDI L. Expression of different tenascin isoforms in normal, hyperplastic and neoplastic breast tissues. Int J Cancer 1992; 52: 688-92.
13. BORSI L, CARNEMOLLA B, PONASSI M, ZARDI L. Steady-state levels of different tenascin mRNAs in various normal tissues. Cell Biol Int 1993; 17: 325-9.
14. SCHWOGLER S, ODENTHAL M, MEYER ZUM BUSCHENFELDE KH, RAMADORI G. Alternative splicing products of the tenascin gene distinguish rat liver fat storing cells from arterial smooth muscle cells and skin fibroblasts. Biochem Biophys Res Commun 1992; 185: 768-75.
15. BORSI L, BALZA E, GAGGERO B, ALLEMANNI G, ZARDI L. The alternative splicing pattern of the tenascin - C pre-mRNA is controlled by the extracellular pH. J Biol Chem 1995; 270: 6243-5.
16. SIRI A, KNAUPERS V, VEIRANA N, CAOCCI F, MURPHY G, ZARDI L Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem 1995; 270: 8650-4.
17. JUHASZ I, MURPHY GF, YAN HC, HERLYN M, ALBELDA SM. Regulation of extracellular matrix proteins and integrin receptors on epithelium during cutaneous human wound healing in-vivo. Am J Pathol 1993; 143: 1458-69.
18. LUOMANEN M, VIRTANEN I. Distribution of tenascin in healing incision, excision and laser wounds. J Oral Pathol Med 1993; 22: 41-5.
19. EDELMAN GM, JONES FS. Cytotactin: a morphoregulatory molecule and a target for regulation by homeobox gene products. TIBS 1992; 17: 228-32.
20. SHRESTHA P, SAKAMOTO F, TAKAGI H, YAMADA T, MORI M. Enhanced tenascin immunoreactivity in leukoplakia and squamous cell carcinoma of the oral cavity: an immunohistochemical study. Oral Oncol, Eur J Cancer 1994; 30B: 132-7.
21. MCCORMICK D, HALL PA. The complexities of proliferating cell nuclear antigen. Histopathology 1992; 21: 591-4.
22. NORENBERG U, HUBERT M, BRUMMEKDORF T, TÁRNOCK A, RATHJEN FG. Characterisation of functional domains of the tenascin-R (restrictin) polypeptide: cell attachment site, binding with F11, and enhancement of F11-mediated neurite out-growth by tenascin-R. J Cell Biol 1995; 130: 473-83.
23. BECKER J, SCHUPPAN D, MULLER S. The immunohistochemical distribution of collagens type I, III, IV, of undulin and of tenascin in oral fibrous hyperplasia. J Oral Pathol Med 1994; 22: 463-7.
24. ZHANG X, SCHUPPAN D, BECKER J, REICHART P, GELDERBLOM HR. Distribution of undulin, tenascin, and fibronectin in the periodontal ligament and cementum: comparative immunoelectron microscopy with ultra-thin cryosections. J Histochem Cytochem 1993; 41: 245-51.
25. MACKIE FJ, TUCKER RP. Tenascin in bone morphogenesis: expression by osteoblasts and cell type-specific expression of splice variants. J Cell Sci 1992; 103: 765-71.
26. WHITBY DJ, LONGAKER MT, HARRISON MR, ADZICK NS, FERGUSON MW. Rapid epithelialisation of fetal wounds is associated with the early deposition of tenascin. J Cell Sci 1991; 99: 583-6.
27. BETZ P, NERLICH A, TUBEL J, PENNING R, EISENMENGER W. Localisation of tenascin in human skin wounds - an immunohistochemical study. Int J Legal Med 1993; 105: 325-8.
28. MCCACHREN SS, LIGHTNER VA. Expression of human tenascin in synovitis and its regulation by interleukin-1. Arthritis Rheum 1992; 35: 1185-96.
29. TIITTA O, WAHLSTROM T, VIRTANEN I, GOULD VE. Tenascin in inflammatory conditions and neoplasms of the urinary bladder. Virchows Archiv B-Cell Pathology 1993; 65: 283-7.
30. CARTER DH, SLOAN P, AARON JE. Immunolocalisation of collagen type I and III, tenascin and fibronectin in intramembranous bone. J Histochem Cytochem 1991; 39: 599-606.
31. TUCKER JE, LEMON R, MACKIE EJ, TUCKER RP. Immunohistochemical localisation of tenascin and fibronectin in the dentine and gingiva of Canis familiaris. Arch Oral Biol 1991; 36: 165-70.
32. MARTIN P, HOPKINSON-WOOLEY J, MCCLUSKEY J. Growth factors and cutaneous wound repair. Prog Growth Factor Res 1992; 4: 25-44.
33. LIGHTNER VA, GUMKOWSKI F, BIGNER DD, ERICKSON HP. Tenascin/hexabrachion in human skin: biochemical identification and localisation by light and electron microscopy. J Cell Biol 1989; 108: 2483-93.
34. MACKIE EJ, HALFTER W, LIVERANI D. Induction of tenascin in healing wounds. J Cell Biol 1988; 107: 2757-67.
35. SCHALKWIJK J, STEIJLEN PM, VAN VLIJMEN- WILLEMS IM, OOSTERLING B, MACKJE EJ, VERSTRAETEN AA. Tenascin expression in human dermis is related to epidermal proliferation. Am J Pathol 1991; 139: 1143-50.
36. RULO HF, VAN VLIJMEN-WILLEMS IM, SCHWALKWIJK J, VERSTRAETEN AA, VAN DE KERKHOF PC. Normal skin demonstrates marked site-variation of tenascin expression, not correlated to epidermal prolif- eration (Ki-67 binding). J Dermatol Sci 1993; 5: 54-7.
37. LIGHTNER VA, ERICKSON HP. Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion. J Cell Sci 1990; 95: 263-77.
38. MURPHY-ULLRICH JE, LIGHTNER VA, AUKHIL, I, YAN YZ, ERICKSON HP, HOOK M. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol 1991; 115: 1127-36.
39. AUKHIL I, JOSHI P, YAN Y, ERICKSON HP. Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins. J Biol Chem 1993; 268: 2542-53.